Extranodal MZL prog list

Flow
Tutorial

Myeloproliferative neoplasms	Neoplasms with eosinophilia (PDGRA/PDGFRB/FGFR1)	MDS/MPN	MDS	AML	Acute leukemia ambiguous lineage
Precursor lymphoid neoplasms	Mature B cell neoplasms	Mature T and NK neoplasms	Hodgkin lymphoma	Immunodeficiency associated lymphoproliferative disorders	Histiocytic and dendritic cell neoplasms

Extranodal Marginal Zone Lymphoma of Mucosa Associated Lymphoid Tissue (MALT Lymphoma)
	Unusual antigen expression abstracts	Prognostic abstracts	Cytogenetic abstracts	Antigen chart

B cell prolymphocytic leukemia

Splenic B cell marginal zone lymphoma

Hairy cell leukemia

Splenic B cell lymphoma / leukemia

Lymphoplasmacytic lymphoma

Heavy chain disease

Nodal marginal zone lymphoma

Primary cutaneous follicle center lymhoma

DLBCL associated with chronic inflammation

Lymphomatoid granulomatosis

Primary mediastinal large B cell lymphoma

Intravascular large B cell lymphoma

ALK positive large B cell lymphoma

Plasmablastic lymphoma

Large B cell lymphoma - HHV8 associated multicentric Castleman

Primary effusion lymphoma

Burkitt lymphoma

B cell lymphoma, unclassifiable with features of DLBCL and Burkitt

B cell lymphoma, unclassifiable with features of DLBCL and Hodgkin

Article	Notes
Favorable Disease
High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6-deregulating mutations, in gastric lymphoma.	Bcl-6 expression compared with promoter region mutations